» Articles » PMID: 23205308

Radiotherapy Versus Stenting in Treating Malignant Dysphagia

Overview
Date 2012 Dec 4
PMID 23205308
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The most commonly used treatments for maliganat dysphagia are stenting and radiotherapy (RT). A prospective data of 91 patients with locally advanced or metastatic esophageal cancer who has been treated with either palliative RT, stent or both. Group I had RT only, Group II had stent only and group III had both RT and stent. The median overall survival was 169, 119 and 237 in the three groups respectively. The difference between GI & III was statistically significant (P=0.01). Combinations of stent and RT may provide survival benefit in patients with malignant dysphagia. A randomized clinical trial is recommended.

Citing Articles

Endoscopic Stenting for Malignant Dysphagia in Patients with Esophageal Cancer.

Ishihara R Curr Oncol. 2023; 30(7):5984-5994.

PMID: 37504308 PMC: 10378447. DOI: 10.3390/curroncol30070447.


Optimal Management of Dysphagia in Patients with Inoperable Esophageal Cancer: Current Perspectives.

Mohapatra S, Santharaman A, Gomez K, Pannala R, Kachaamy T Cancer Manag Res. 2022; 14:3281-3291.

PMID: 36448034 PMC: 9701451. DOI: 10.2147/CMAR.S362666.


Palliative radiotherapy combined with stent insertion to relieve dysphagia in advanced esophageal carcinoma patients: A systematic review and meta-analysis.

Xu Z, Liu H, Li S, Han Z, Chen J, Liu X Front Oncol. 2022; 12:986828.

PMID: 36172146 PMC: 9511165. DOI: 10.3389/fonc.2022.986828.


Single modality radical radiotherapy is an acceptable alternative for the older patient with squamous cell carcinoma of the oesophagus.

Derby S, Forshaw M, Lowrie C, Grose D, Marashi H, McLoone P BMJ Open Gastroenterol. 2021; 8(1).

PMID: 33504498 PMC: 7843319. DOI: 10.1136/bmjgast-2020-000492.


Aortic pseudoaneurysm formation following concurrent chemoradiotherapy and metallic stent insertion in a patient with esophageal cancer.

Hou P, Teng C, Chung C, Liu C, Huang C, Chang M Medicine (Baltimore). 2015; 94(20):e862.

PMID: 25997064 PMC: 4602863. DOI: 10.1097/MD.0000000000000862.


References
1.
Song H, Lee D, Seo T, Kim S, Jung H, Kim J . Retrievable covered nitinol stents: experiences in 108 patients with malignant esophageal strictures. J Vasc Interv Radiol. 2002; 13(3):285-93. DOI: 10.1016/s1051-0443(07)61722-9. View

2.
Conio M, Repici A, Battaglia G, De Pretis G, Ghezzo L, Bittinger M . A randomized prospective comparison of self-expandable plastic stents and partially covered self-expandable metal stents in the palliation of malignant esophageal dysphagia. Am J Gastroenterol. 2007; 102(12):2667-77. DOI: 10.1111/j.1572-0241.2007.01565.x. View

3.
Siersema P . Esophageal cancer. Gastroenterol Clin North Am. 2008; 37(4):943-64, x. DOI: 10.1016/j.gtc.2008.09.012. View

4.
Allum W, Griffin S, Watson A, Colin-Jones D . Guidelines for the management of oesophageal and gastric cancer. Gut. 2002; 50 Suppl 5:v1-23. PMC: 1867706. DOI: 10.1136/gut.50.90005.v1. View

5.
Homs M, Steyerberg E, Eijkenboom W, Tilanus H, Stalpers L, Bartelsman J . Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet. 2004; 364(9444):1497-504. DOI: 10.1016/S0140-6736(04)17272-3. View